La eritropoyetina humana recombinante como terapia para la neuroprotección en la isquemia cerebral

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biotecnología Aplicada

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PASO DE LA MOLÉCULA DE ERITROPOYETINA HUMANA RECOMBINANTE CON BAJO CONTENIDO DE ÁCIDO SIÁLICO AL SISTEMA NERVIOSO CENTRAL POR LA VÍA INTRANASAL EN LOS MODELOS DEL Meriones unguiculatus Y EL PRIMATE NO HUMANO Macaca fascicularis

  2008cited by this paper
• Neuroprotección en la isquemia cerebral: experiencias con la eritropoyetina humana recombinante

  2007cited by this paper
• Reduced Functional Deficits, Neuroinflammation, and Secondary Tissue Damage after Treatment of Stroke by Nonerythropoietic Erythropoietin Derivatives

  2007cited by this paper
• Guías de práctica clínica para las enfermedades cerebrovasculares

  2007cited by this paper
• Pathophysiology and Therapy of Experimental Stroke

  2006cited by this paper
• Development of Non-Erythropoietic Erythropoietin Variants for Neuroprotection

  2006cited by this paper
• Toward a Multimodal Neuroprotective Treatment of Stroke

  2006cited by this paper
• Erythropoietin for Treatment of Human Brain Disease: Experience from Proof-of-Concept Trials

  2006cited by this paper
• INTRANASAL ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN EXERTS NEUROPROTECTIVE EFFECTS ON POST-ISCHEMIC BRAIN INJURY IN MONGOLIAN GERBILS.

  2006cited by this paper
• Neuroprotective Effect of Darbepoetin Alfa, a Novel Recombinant Erythropoietic Protein, in Focal Cerebral Ischemia in Rats

  2005cited by this paper
• Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.

  2005cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005cited by this paper
• Criterios preclnicos que sustentan el uso de la eritropoyetina recombinante humana

  2005cited by this paper
• Erythropoietin after Focal Cerebral Ischemia Activates the Janus Kinase–Signal Transducer and Activator of Transcription Signaling Pathway and Improves Brain Injury in Postnatal Day 7 Rats

  2005cited by this paper
• Astroglial cytoprotection by erythropoietin pre‐conditioning: implications for ischemic and degenerative CNS disorders

  2005cited by this paper
• A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.

  2005cited by this paper
• Erythropoietin Enhances Neurogenesis and Restores Spatial Memory in Rats after Traumatic Brain Injury

  2005cited by this paper
• Erythropoietin Improves Functional and Histological Outcome in Neonatal Stroke

  2005cited by this paper
• Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.

  2005cited by this paper
• Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

  2005cited by this paper
• Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic

  2004cited by this paper
• Erythropoietin both protects from and reverses experimental diabetic neuropathy.

  2004cited by this paper
• Increased Expression of Erythropoietin Receptor on Blood Vessels in the Human Epileptogenic Hippocampus with Sclerosis

  2004cited by this paper
• Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.

  2004cited by this paper
• Erythropoietin: a candidate compound for neuroprotection in schizophrenia

  2004cited by this paper
• Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis

  2004cited by this paper
• Erythropoietin: Novel Approaches to Neuroprotection in Human Brain Disease

  2004cited by this paper
• Understanding the pattern of functional recovery after stroke: facts and theories.

  2004cited by this paper
• Protección neuronal endógena: un enfoque alternativo

  2004cited by this paper
• Fisiopatología de la isquemia cerebral focal: aspectos básicos y proyección a la clínica

  2004cited by this paper
• Are the Extracellular Pathways a Conduit for the Delivery of Therapeutics to the Brain

  2004cited by this paper
• Mecanismos celulares y moleculares de la enfermedad cerebrovascular isquémica

  2004cited by this paper
• Animal models of focal and global cerebral ischemia.

  2003cited by this paper
• Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability

  2003cited by this paper
• Ischemic tolerance and endogenous neuroprotection.

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications.

  2003cited by this paper
• Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo

  2003cited by this paper
• Central nervous system frontiers for the use of erythropoietin.

  2003cited by this paper
• Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats

  2003cited by this paper
• Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model

  2002cited by this paper
• Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

  2002cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Erythropoietin--an endogenous retinal survival factor.

  2002cited by this paper
• Neuromodulación farmacológica en la enfermedad cerebrovascular

  2002cited by this paper
• Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain

  2002cited by this paper
• Oral administration of a soy extract improves endothelial dysfunction in ovariectomized rats.

  2002cited by this paper
• Erythropoietin in the central nervous system, and its use to prevent hypoxic‐ischemic brain damage

  2002cited by this paper
• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

  2002cited by this paper
• Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

  2002cited by this paper
• Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils.

  2002cited by this paper
• Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures.

  2002cited by this paper
• Neuroprotective properties of epoetin alfa.

  2002cited by this paper
• Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases

  2002cited by this paper
• Beyond erythropoiesis: novel applications for recombinant human erythropoietin.

  2001cited by this paper
• Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain

  2001cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Erythropoietin and Erythropoietin Receptors in Human CNS Neurons, Astrocytes, Microglia, and Oligodendrocytes Grown in Culture

  2001cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Erythropoietin – a novel concept for neuroprotection

  2001cited by this paper
• Erythropoietin Regulates the In Vitro and In Vivo Production of Neuronal Progenitors by Mammalian Forebrain Neural Stem Cells

  2001cited by this paper
• Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage.

  2001cited by this paper
• Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical.

  2000cited by this paper
• Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage.

  2000cited by this paper
• Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation.

  2000cited by this paper
• Differential Glial and Vascular Expression of Endothelins and Their Receptors in Rat Brain after Neurotrauma

  2000cited by this paper
• [The objective of acute stroke therapy and neuroprotective therapeutic approaches].

  1999cited by this paper
• Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

  1999cited by this paper
• Applied anatomy and physiology of the nose and paranasal sinuses

  1999cited by this paper
• Immunohistochemical Localization of Erythropoietin and Its Receptor in the Developing Human Brain

  1999cited by this paper
• In vivo evidence that erythropoietin protects neurons from ischemic damage.

  1998cited by this paper
• Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain.

  1997cited by this paper
• Neuroprotective Strategies for Early Intervention in Acute Ischaemic Stroke: Janssen-Cilag Satellite Meeting to the 3rd World Stroke Congress and the 5th European Stroke Conference, Munich, September 1996

  1997cited by this paper
• Ischemic tolerance in moderately symptomatic gerbils after unilateral carotid occlusion.

  1996cited by this paper
• Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

  1996cited by this paper
• Pharmacology of Cerebral Ischemia

  1992cited by this paper
• Rodent models of cerebral ischemia.

  1989cited by this paper
• Erythropoietic Action of Tissue Extracts

  1962cited by this paper
• The FASEB Journal express article 10.1096/fj.05-3907fje. Published online August 12, 2005. ©2005 FASEB

  year unknowncited by this paper

• Intracranial collateral circulation and its role in neurovascular pathology

  2021cites this paper
• Evaluación de la glicosilación tipo O-GlcNAc en el hipocampo de rata sometida a isquemia cerebral focal

  2017cites this paper
• Factores que intervienen en el diseño de sistemas de liberación nasal de péptidos y proteínas

  2013cites this paper
• Factors involved in the design of nasal delivery systems for peptides and proteins

  2013cites this paper
• Erythropoietin: still on the neuroprotection road

  2012cites this paper
• Estrategias para la prevención y control de las enfermedades cerebrovasculares

  2012influential citation